These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16641847)

  • 21. Selective serotonin reuptake inhibitors and treatment of premenstrual dysphoric disorder.
    Finfgeld DL
    Perspect Psychiatr Care; 2002; 38(2):50-60. PubMed ID: 12132631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premenstrual syndrome. Advances in diagnosis and treatment.
    Kessel B
    Obstet Gynecol Clin North Am; 2000 Sep; 27(3):625-39. PubMed ID: 10958008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premenstrual dysphoric disorder: burden of illness and treatment update.
    Pearlstein T; Steiner M
    J Psychiatry Neurosci; 2008 Jul; 33(4):291-301. PubMed ID: 18592027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The premenstrual syndrome].
    van der Leij F; Schultz WC; van de Wiel H; van Leeuwen JH
    Ned Tijdschr Geneeskd; 2010; 154():A1341. PubMed ID: 20719012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premenstrual Dysphoric Disorder.
    Lanza di Scalea T; Pearlstein T
    Psychiatr Clin North Am; 2017 Jun; 40(2):201-216. PubMed ID: 28477648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
    Yang J; Joe SH; Lee MS; Kim SH; Jung IK
    Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient information. What is premenstrual dysphoric disorder (PMDD)?
    Cleve Clin J Med; 2004 Apr; 71(4):322. PubMed ID: 15117172
    [No Abstract]   [Full Text] [Related]  

  • 30. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing PMS & PMDD. Exploring new treatment options.
    Pritham UA
    AWHONN Lifelines; 2002; 6(5):430-7. PubMed ID: 12420386
    [No Abstract]   [Full Text] [Related]  

  • 32. YAZ in the treatment of premenstrual dysphoric disorder.
    Rapkin AJ
    J Reprod Med; 2008 Sep; 53(9 Suppl):729-41. PubMed ID: 18980045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
    Steiner M; Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premenstrual Dysphoric Disorder.
    Lanza di Scalea T; Pearlstein T
    Med Clin North Am; 2019 Jul; 103(4):613-628. PubMed ID: 31078196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca].
    McHichi alami Kh; Tahiri SM; Moussaoui D; Kadri N
    Encephale; 2002; 28(6 Pt 1):525-30. PubMed ID: 12506265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sertraline in the treatment of premenstrual dysphoric disorder].
    Culav-Sumić J; Skocilić Z; Jukić V
    Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).
    Halbreich U; Borenstein J; Pearlstein T; Kahn LS
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():1-23. PubMed ID: 12892987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan.
    Yoshimi K; Inoue F; Odai T; Shirato N; Watanabe Z; Otsubo T; Terauchi M; Takeda T
    J Obstet Gynaecol Res; 2023 May; 49(5):1375-1382. PubMed ID: 36822597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SSRIs for premenstrual dysphoric disorder.
    Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.